​​Investigator-Initiated Trials: Now Recruiting: A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for PTSD

On October 4, 2021, Dr. Anne Wagner and a team of researchers at Remedy Institute in Toronto, Ontario, Canada, began studying MDMA-assisted cognitive processing therapy (CPT) for individuals with posttraumatic stress disorder (PTSD). This study is an investigator-initiated trial and is currently recruiting. Visit the official study page on clinicaltrials.gov to learn more.